Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Ra Capital Management, L.P. reported a 11.20% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Dec 8, 2025 · Filed Dec 10, 2025
Ra Capital Management, L.P. reported a 11.20% stake in Fulcrum Therapeutics, Inc., 6,053,960 shares, as a passive investor on Dec 8, 2025. Filed Dec 10, 2025 (Schedule 13G/A).
- Stake
- 11.20%
- Shares
- 6,053,960
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 11.20% | 6,053,960 |
| Peter Kolchinsky | 11.20% | 6,053,960 |
| Rajeev Shah | 11.20% | 6,053,960 |
| RA Capital Healthcare Fund, L.P. | 11.20% | 6,053,960 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Ra Capital Management, L.P.
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026